356 related articles for article (PubMed ID: 33574689)
21. PHD3 as a Prognosis Marker and its Relationship with Immune Infiltration in Lung Adenocarcinoma.
Wang L; Zhong Y; Wang G; An H; Gao Q; Ye Y
Comb Chem High Throughput Screen; 2022; 25(13):2255-2263. PubMed ID: 35088661
[TBL] [Abstract][Full Text] [Related]
22. Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma.
Xu ZY; Zhao M; Chen W; Li K; Qin F; Xiang WW; Sun Y; Wei J; Yuan LQ; Li SK; Lin SH
PeerJ; 2020; 8():e9530. PubMed ID: 32775050
[TBL] [Abstract][Full Text] [Related]
23. Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment.
Zeng Q; Sun S; Li Y; Li X; Li Z; Liang H
Front Oncol; 2019; 9():1555. PubMed ID: 32117786
[No Abstract] [Full Text] [Related]
24. Comprehensive Analysis Reveals the Potential Roles of Transcription Factor Dp-1 in Lung Adenocarcinoma.
Song Y; Ma R
World J Oncol; 2023 Jun; 14(3):205-223. PubMed ID: 37350808
[TBL] [Abstract][Full Text] [Related]
25. KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker.
Shen X; Mo X; Tan W; Mo X; Li L; Yu F; He J; Deng Z; Xing S; Chen Z; Yang J
Pathol Oncol Res; 2022; 28():1610754. PubMed ID: 36419650
[No Abstract] [Full Text] [Related]
26. Independent prognostic implications of
Ma C; Luo H; Cao J; Gao C; Fa X; Wang G
J Cancer; 2020; 11(23):7009-7022. PubMed ID: 33123291
[No Abstract] [Full Text] [Related]
27. Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma.
Liu M; Huang L; Liu Y; Yang S; Rao Y; Chen X; Nie M; Liu X
J Transl Med; 2023 Mar; 21(1):208. PubMed ID: 36941602
[TBL] [Abstract][Full Text] [Related]
28. CC chemokine receptors are prognostic indicators of gastric cancer and are associated with immune infiltration.
Liao X; Yang Y; Wang L; Kong Z; Li W
BMC Med Genomics; 2024 Jan; 17(1):1. PubMed ID: 38169378
[TBL] [Abstract][Full Text] [Related]
29. Identification of Therapeutic Targets and Prognostic Biomarkers Among Chemokine (C-C Motif) Ligands in the Liver Hepatocellular Carcinoma Microenvironment.
Jiang Z; Xing C; Wang P; Liu X; Zhong L
Front Cell Dev Biol; 2021; 9():748269. PubMed ID: 34938730
[No Abstract] [Full Text] [Related]
30. A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma.
Yang X; Wang G; Gu R; Xu X; Zhu G
PeerJ; 2020; 8():e10418. PubMed ID: 33304656
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic values.
Hu LT; Deng WJ; Chu ZS; Sun L; Zhang CB; Lu SZ; Weng JR; Ren QS; Dong XY; Li WD; Li XB; Du YT; Li Y; Wang WQ
BMC Pulm Med; 2022 Jun; 22(1):259. PubMed ID: 35768814
[TBL] [Abstract][Full Text] [Related]
33. Downregulated Expression of CLEC9A as Novel Biomarkers for Lung Adenocarcinoma.
Miao F; Lou Z; Ji S; Wang D; Sun Y; Liu H; Yang C
Front Oncol; 2021; 11():682814. PubMed ID: 34616670
[TBL] [Abstract][Full Text] [Related]
34. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
Chen D; Luo L; Liang C
PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
[TBL] [Abstract][Full Text] [Related]
35. Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma.
Guo W; Huai Q; Zhang G; Guo L; Song P; Xue X; Tan F; Xue Q; Gao S; He J
Front Oncol; 2020; 10():598437. PubMed ID: 33569346
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the Oncogene Function of GOLPH3 and Correlated Regulatory Network in Lung Adenocarcinoma.
Zhang T; Wang Y; Chen Y; Jin S; Gao Y; Zhang D; Wu Y
Front Oncol; 2021; 11():669684. PubMed ID: 34497755
[TBL] [Abstract][Full Text] [Related]
37. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma.
Bian T; Zheng M; Jiang D; Liu J; Sun H; Li X; Liu L; Zhang J; Liu Y
Cancer Cell Int; 2021 Mar; 21(1):144. PubMed ID: 33653340
[TBL] [Abstract][Full Text] [Related]
38. Integrative Multi-Omics Analysis of Identified SKA3 as a Candidate Oncogene Correlates with Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma.
Lin Y; An J; Zhuo X; Qiu Y; Xie W; Yao W; Yin D; Wu L; Lei D; Li C; Xie Y; Hu A; Li S
Int J Gen Med; 2022; 15():4635-4647. PubMed ID: 35535142
[TBL] [Abstract][Full Text] [Related]
39. ZC3H12D is a prognostic biomarker associated with immune cell infiltration in lung adenocarcinoma.
Gong W; Dai W; Wei H; Chen Y; Zheng Z
Transl Cancer Res; 2020 Oct; 9(10):6128-6142. PubMed ID: 35117224
[TBL] [Abstract][Full Text] [Related]
40. Expression, Prognosis and Gene Regulation Network of NFAT Transcription Factors in Non-Small Cell Lung Cancer.
Ma J; Du R; Huang Y; Zhong W; Gui H; Mao C; Song X; Lu J
Pathol Oncol Res; 2021; 27():529240. PubMed ID: 34257525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]